The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on positive results from the ...

Bayer AG won the backing of European Union regulators for its cardiology drug as the German company fights to offset the ...

Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...

BridgeBio Pharma (BBIO) announced the Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion ...

The findings could potentially enable patients to be identified and treated before symptoms of ATTR-CM emerge.

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended another batch medicines for approval at ...

The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed ...

Amyloidosis is a rare, multisystem disease that leads to deposition of misfolded proteins in various organs. This case report ...

The new understanding of molecular events that drive the various forms of amyloidosis has generated treatment strategies that ...

Near-complete in vitro TTR stabilization was observed as early as day 28 and through completion of a 30-month study of patients with ATTR-CM. The Food and Drug Administration (FDA) has approved ...

See the new treatment that will break a Pfizer monopoly on a drug for heart disease.

UK: A recent retrospective cohort study has highlighted the critical role of kidney function in patients diagnosed with ...